These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21508321)

  • 1. Composite scaffold provides a cell delivery platform for cardiovascular repair.
    Godier-Furnémont AF; Martens TP; Koeckert MS; Wan L; Parks J; Arai K; Zhang G; Hudson B; Homma S; Vunjak-Novakovic G
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7974-9. PubMed ID: 21508321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.
    Atluri P; Miller JS; Emery RJ; Hung G; Trubelja A; Cohen JE; Lloyd K; Han J; Gaffey AC; MacArthur JW; Chen CS; Woo YJ
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1090-7; discussion 1097-8. PubMed ID: 25129603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alignment of inducible vascular progenitor cells on a micro-bundle scaffold improves cardiac repair following myocardial infarction.
    Jamaiyar A; Wan W; Ohanyan V; Enrick M; Janota D; Cumpston D; Song H; Stevanov K; Kolz CL; Hakobyan T; Dong F; Newby BZ; Chilian WM; Yin L
    Basic Res Cardiol; 2017 Jul; 112(4):41. PubMed ID: 28540527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modifying decellularized aortic valve scaffolds with stromal cell-derived factor-1α loaded proteolytically degradable hydrogel for recellularization and remodeling.
    Dai J; Qiao W; Shi J; Liu C; Hu X; Dong N
    Acta Biomater; 2019 Apr; 88():280-292. PubMed ID: 30721783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biohybrid cardiac ECM-based hydrogels improve long term cardiac function post myocardial infarction.
    Efraim Y; Sarig H; Cohen Anavy N; Sarig U; de Berardinis E; Chaw SY; Krishnamoorthi M; Kalifa J; Bogireddi H; Duc TV; Kofidis T; Baruch L; Boey FYC; Venkatraman SS; Machluf M
    Acta Biomater; 2017 Mar; 50():220-233. PubMed ID: 27956366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction.
    Fitzpatrick JR; Frederick JR; McCormick RC; Harris DA; Kim AY; Muenzer JR; Gambogi AJ; Liu JP; Paulson EC; Woo YJ
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):667-76. PubMed ID: 20363480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats.
    Cui X; Wang H; Guo H; Wang C; Ao H; Liu X; Tan YZ
    Tohoku J Exp Med; 2010 Feb; 220(2):139-47. PubMed ID: 20139665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction.
    Blondiaux E; Pidial L; Autret G; Rahmi G; Balvay D; Audureau E; Wilhelm C; Guerin CL; Bruneval P; Silvestre JS; Menasché P; Clément O
    J Tissue Eng Regen Med; 2017 Dec; 11(12):3417-3427. PubMed ID: 28156084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium.
    Bearzi C; Gargioli C; Baci D; Fortunato O; Shapira-Schweitzer K; Kossover O; Latronico MV; Seliktar D; Condorelli G; Rizzi R
    Cell Death Dis; 2014 Feb; 5(2):e1053. PubMed ID: 24525729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis.
    Frederick JR; Fitzpatrick JR; McCormick RC; Harris DA; Kim AY; Muenzer JR; Marotta N; Smith MJ; Cohen JE; Hiesinger W; Atluri P; Woo YJ
    Circulation; 2010 Sep; 122(11 Suppl):S107-17. PubMed ID: 20837901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia.
    See F; Seki T; Psaltis PJ; Sondermeijer HP; Gronthos S; Zannettino AC; Govaert KM; Schuster MD; Kurlansky PA; Kelly DJ; Krum H; Itescu S
    J Cell Mol Med; 2011 Oct; 15(10):2117-29. PubMed ID: 21155976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of high bioactivity multilayered bone-marrow mesenchymal stem cell sheets for myocardial infarction using a 3D-dynamic system.
    Wang Y; Zhang J; Qin Z; Fan Z; Lu C; Chen B; Zhao J; Li X; Xiao F; Lin X; Wu Z
    Acta Biomater; 2018 May; 72():182-195. PubMed ID: 29627677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair.
    Jang J; Park HJ; Kim SW; Kim H; Park JY; Na SJ; Kim HJ; Park MN; Choi SH; Park SH; Kim SW; Kwon SM; Kim PJ; Cho DW
    Biomaterials; 2017 Jan; 112():264-274. PubMed ID: 27770630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailoring material properties of cardiac matrix hydrogels to induce endothelial differentiation of human mesenchymal stem cells.
    Jeffords ME; Wu J; Shah M; Hong Y; Zhang G
    ACS Appl Mater Interfaces; 2015 May; 7(20):11053-61. PubMed ID: 25946697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decellularized myocardial matrix hydrogels: In basic research and preclinical studies.
    Wang RM; Christman KL
    Adv Drug Deliv Rev; 2016 Jan; 96():77-82. PubMed ID: 26056717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
    Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
    Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin-Enriched Cardiac Extracellular Matrix Hydrogel Promotes
    Shaik R; Xu J; Wang Y; Hong Y; Zhang G
    ACS Biomater Sci Eng; 2023 Feb; 9(2):877-888. PubMed ID: 36630688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decellularized Aortic Scaffold Alleviates H
    Gao L; Feng A; Li C; Schmull S; Sun H
    Biomed Res Int; 2020; 2020():6782072. PubMed ID: 32104703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electromechanical Conditioning of Adult Progenitor Cells Improves Recovery of Cardiac Function After Myocardial Infarction.
    Llucià-Valldeperas A; Soler-Botija C; Gálvez-Montón C; Roura S; Prat-Vidal C; Perea-Gil I; Sanchez B; Bragos R; Vunjak-Novakovic G; Bayes-Genis A
    Stem Cells Transl Med; 2017 Mar; 6(3):970-981. PubMed ID: 28297585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A PEGylated platelet free plasma hydrogel based composite scaffold enables stable vascularization and targeted cell delivery for volumetric muscle loss.
    Aurora A; Wrice N; Walters TJ; Christy RJ; Natesan S
    Acta Biomater; 2018 Jan; 65():150-162. PubMed ID: 29128541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.